Recent Episodes
Watch recent episodes on
PTV News Review
Scroll Left
Scroll Right
MorphoSys: Dr Simon Moroney, CEO




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: MorphoSys: Dr Simon Moroney, CEO
Released on: November 01, 2006. © PharmaVentures Ltd
Visitors: You are watching a 5 minute preview.
Get more information and subscribe now
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    Simon Moroney talks to Fintan Walton about the founding and history of MorphoSys, its alliance management model and the challenges of maintaining successful partnerships in parallel with internal drug development programmes.
  • Summary
  • Transcript
  • Participants
  • Company
Simon Moroney talks to Fintan Walton about the founding and history of MorphoSys, its alliance management model and the challenges of maintaining successful partnerships in parallel with internal drug development programmes. They discuss MorphoSys' long-term strategic partnership with Roche and the rewards that the relationship has brought both companies, as well as the company's strategy going forward. Dr Moroney also outlines MorphoSys’ drug development programme and the strategic reasoning behind the company’s decision to drive growth by business acquisitions in the US. Finally, the impact that the recent consolidation of mid-sized German pharmaceutical companies might have on MorphoSys ongoing scheme of operations is discussed.
Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.
Dr Simon E Moroney is one of MorphoSys’s co-founders. He studied chemistry in his native New Zealand, and was a Commonwealth Scholar to the University of Oxford, where he completed a DPhil in Chemistry in 1984. Before co-founding MorphoSys in 1992, Dr Moroney held positions at the University of Cambridge, UK, at the University of British Columbia, Canada, and in the Chemistry Department of the ETH in Zurich, Switzerland. Subsequently he was an Associate in the Harvard Medical School, Boston, US, and an employee of ImmunoGen, where he worked on the development of antibody-based cancer drugs.

In 2002, Dr Moroney was awarded the Bundesverdienstkreuz am Bande (Cross of the Order of Merit of the Federal Republic of Germany) for his services to the biotechnology industry.
MorphoSys AG